SLC3A2 and prostate adenocarcinoma: On the contrary, SLC3A2 was positively correlated with immune infiltrates in PRAD and PCPG, which suggested that SLC3A2 may play distinct roles in different cancer types in terms of immune cell recruitment (Figure 4D).